The messenger RNA vaccine BNT162b2 (Pfizer–BioNTech) has 95% efficacy against coronavirus disease 2019 (Covid-19).1 Qatar launched a mass immunization campaign with this vaccine on December 21, 2020. As of March 31, 2021, a total of 385,853 persons had received at least one vaccine dose and 265,410 had completed the two doses. […]
The CDC is expected to sign off on the move Wednesday, making Thursday the first day shots could be available for children 12 to 15 years old. By Erika Edwards. The Food and Drug Administration on Monday lowered the age that people can receive Pfizer’s Covid-19 vaccine in the United States […]
Las autoridades de Canadá aprobaron la mañana de este miércoles el uso de la vacuna contra el Covid-19 de Pfizer-BioNTech. Después de varias investigaciones, filtros y pruebas Canadá se ha convertido en el primer país en aprobar la vacuna COVID de Pfizer para menores a partir de los 12 años. […]
Pfizer CEO Albert Bourla says an oral drug the company is developing to treat COVID-19 symptoms could be available to the public by the end of the year. “If all goes well, and we implement the same speed that we are, and if regulators do the same, and they are, […]
Redacción Médica analiza las disimilitudes entre la eficacia, el tiempo de protección o su conservación, entre otros Estados Unidos ya ha aprobado la vacuna de Janssen contra el Covid-19 para su uso de emergencia. La compañía farmacéutica suministrará hasta 200 millones de dosis a la Unión Europea a lo largo de 2021. Hasta […]
Analysis of 927 confirmed symptomatic cases of COVID-19 demonstrates BNT162b2 is highly effective with 91.3% vaccine efficacy observed against COVID-19, measured seven days through up to six months after the second dose Vaccine was 100% effective in preventing severe disease as defined by the U.S. Centers for Disease Control and […]
Pfizer and BioNTech have asked the US Food and Drug Administration (FDA) to expand authorization of their COVID vaccine to include children as young as 12 years of age. The companies said they plan to ask for similar rulings by other regulatory bodies around the world in coming days. The request follows […]
Vaccination with the Pfizer or Moderna vaccine reduces infections by 90%, while a single dose confers 80% protection, shows a study led by the US Centers for Disease Control and Prevention (CDC) that followed essential workers through the worst months of the pandemic. The study is one of a small […]
The Pfizer Inc.-BioNTech SE vaccine remained highly effective against Covid-19 after six months, according to new long-term results that Pfizer said could be used to seek an expansion of the shot’s regulatory status. Follow-up data from a final-stage trial of 46,307 people showed the vaccine was 91.3% effective in preventing […]
Nueva York,.- Las farmacéuticas Pfizer y BioNTech informaron este jueves de que su vacuna contra Covid-19 sigue siendo altamente efectiva durante al menos seis meses después de administrarse la segunda dosis y que además funciona contra la variante sudafricana del virus. Las conclusiones proceden de un seguimiento de los voluntarios […]
